NewsBenzinga액티늄 파마, 2026년 ESMO 학회에서 전이성 거세 저항성 전립선암 대상 HER3 표적 비PSMA 방사선 치료제 ATNM-400의 최초 인체 1상 연구 결과 발표 예정 액티늄 파마, 2026년 ESMO 학회에서 전이성 거세 저항성 전립선암 대상 HER3 표적 비PSMA 방사선 치료제 ATNM-400의 최초 인체 1상 연구 결과 발표 예정 Benzinga 2026.10.23 12:05 (GMT+0) Open on Benzinga Other news NVIDIA Interim CEO Colette Kress Says Vera Rubin Is Off To An Explosive Start, Our Roadmap Is On Track And Our Ambition Has Never Been Greater Here’s How Much You Would Have Made Owning Marvell Technology Stock In The Last 20 Years NVIDIA Sees Q4 Sales $126.100B-$133.900B vs $125.163B Est NVIDIA Q3 Adj. EPS $2.68 Beats $2.48 Estimate, Sales $115.844B Beat $109.080B Estimate Dolby Laboratories Sees Q1 GAAP EPS $0.01-$0.16 vs $0.76 Est Dolby Laboratories Sees Q1 Adj EPS $0.41-$0.56 vs $1.12 Est; Sees Sales $285.000M-$305.000M vs $359.329M Est
NVIDIA Interim CEO Colette Kress Says Vera Rubin Is Off To An Explosive Start, Our Roadmap Is On Track And Our Ambition Has Never Been Greater
Dolby Laboratories Sees Q1 Adj EPS $0.41-$0.56 vs $1.12 Est; Sees Sales $285.000M-$305.000M vs $359.329M Est